pyrazolanthrone has been researched along with B16 Melanoma in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chung, YC; Hyun, CG; Kim, SY | 1 |
Chang, SP; Chen, YC; Huang, HM; Lee, WR; Shen, SC | 1 |
Chang, SP; Chen, YC; Lee, WR; Shen, SC; Yang, LL | 1 |
Im, SY; Kim, HA; Kim, KJ; Lee, HK; Seo, KH | 1 |
4 other study(ies) available for pyrazolanthrone and B16 Melanoma
Article | Year |
---|---|
8-Methoxycoumarin enhances melanogenesis
Topics: Animals; Anthracenes; Coumarins; Cyclic AMP-Dependent Protein Kinases; Dose-Response Relationship, Drug; Imidazoles; MAP Kinase Signaling System; Melanins; Melanoma, Experimental; Mice; Proto-Oncogene Proteins c-akt; Pyridines; Ruta; Signal Transduction | 2019 |
Nilotinib induction of melanogenesis via reactive oxygen species-dependent JNK activation in B16F0 mouse melanoma cells.
Topics: Animals; Anthracenes; Antioxidants; Apoptosis; Caspase 3; Cell Line, Tumor; Cell Survival; Enzyme Activation; Imatinib Mesylate; MAP Kinase Kinase 4; Melanins; Melanocytes; Melanoma, Experimental; Mice; Mitochondria; Protein-Tyrosine Kinases; Pyrimidines; Reactive Oxygen Species | 2018 |
Imatinib mesylate induction of ROS-dependent apoptosis in melanoma B16F0 cells.
Topics: Animals; Anthracenes; Antineoplastic Agents; Apoptosis; Benzamides; Flavonoids; Flow Cytometry; Imatinib Mesylate; Imidazoles; Melanoma, Experimental; Membrane Potentials; Mice; Mitochondria; Piperazines; Protein Kinase Inhibitors; Pyridines; Pyrimidines; Reactive Oxygen Species | 2011 |
PTEN/MAPK pathways play a key role in platelet-activating factor-induced experimental pulmonary tumor metastasis.
Topics: Androstadienes; Animals; Anthracenes; Butadienes; Cell Line; Humans; Imidazoles; Lung Neoplasms; MAP Kinase Signaling System; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinases; Nitriles; Phosphoinositide-3 Kinase Inhibitors; Phosphorylation; Platelet Activating Factor; Proto-Oncogene Proteins c-akt; PTEN Phosphohydrolase; Pyridines; Wortmannin | 2012 |